SpaceX Rocket Launches Intuitive Machines' Athena Lander: Details - Intuitive Machines ( NASDAQ:LUNR )
Athena successfully launched and established communication in space. Intuitive Machines' mission aims for a March 6 lunar landing. Our government trade tracker caught Pelosi's 169% AI winner. Discover how to track all 535 Congress member stock trades today. Intuitive Machines Inc.
Earn $3000 Daily in 2025 with HEXminer's High-Yield Free Bitcoin Cloud Mining ( Altcoins Supported )
London, UK, Feb. 27, 2025 ( GLOBE NEWSWIRE ) -- Cloud mining is a great way to earn passive income with cryptocurrencies, and HEXminer makes it even easier. In 2025, you can start mining free Bitcoin and altcoins with HEXminer's high-yield cloud mining contracts and earn up to $3000 a day-no ...
Joe Rogan Fact Checks And Debunks His 'Favorite Billionaire' Elon Musk's Social Security Claims: 'This Isn't A Vampire Conspiracy'
Joe Rogan, a longtime admirer of Elon Musk, recently pushed back against the billionaire's claims about Social Security fraud, calling them misleading.
THIRD TIME'S A ROAR AS SPIN MASTER UNVEILS TITLE, SYNOPSIS, AND LOGO OF THIRD PAW PATROL® FEATURE FILM - Paramount Glb ( NASDAQ:PARA )
PAW Patrol: The Dino Movie, Starring Mckenna Grace, Jennifer Hudson, and Fortune Feimster, Expands Franchise Based on World's Most Popular Preschool Series TORONTO, Feb. 27, 2025 /PRNewswire/ - Spin Master Corp.
ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX - ESSA Pharma ( NASDAQ:EPIX )
NEW YORK, Feb. 27, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ESSA Pharma Inc. EPIX between December 12, 2023 and October 31, 2024, inclusive ( the "Class Period" ) , of the important March 25, 2025 lead plaintiff ...
Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership
BERKELEY HEIGHTS, N.J., Feb. 27, 2025 ( GLOBE NEWSWIRE ) -- Cyclacel Pharmaceuticals, Inc. ( "Cyclacel" ) ( NASDAQ: CYCC, NASDAQ: CYCCP ) , a biopharmaceutical company that develops innovative cancer medicines, today announced a change in control and leadership on February 26, 2025.
Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership - Cyclacel Pharmaceuticals ( NASDAQ:CYCCP ) , Cyclacel Pharmaceuticals ( NASDAQ:CYCC )
BERKELEY HEIGHTS, N.J., Feb. 27, 2025 ( GLOBE NEWSWIRE ) -- Cyclacel Pharmaceuticals, Inc. ( "Cyclacel" ) CYCCCYCCP, a biopharmaceutical company that develops innovative cancer medicines, today announced a change in control and leadership on February 26, 2025.
C3.ai Sees Stronger Revenue But Analyst Concerned Over Profitability And Scale - C3.ai ( NYSE:AI )
C3.ai beats Q3 revenue and EPS estimates, projects up to $113.6M in Q4 sales JP Morgan cuts C3.ai price target, cites subpar growth and unprofitability concerns Get 5 stock picks identified before their biggest breakouts, identified by the same system that spotted Insmed, Sprouts, and Uber ...
The International Association of Blacks In Dance Announces Appointment of Omar Ingram as Executive Director
Omar Ingram will start as IABD'S Executive Director on March 1, 2025Dr. Natasha Moreland Spears is stepping down as IABD's Co-Executive Director on February 28.
GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription Sales - GoodRx Holdings ( NASDAQ:GDRX )
GoodRx Q4 revenue rose 1% YoY to $198.6M, missing guidance and estimates. Adjusted EPS of $0.09 missed the $0.10 consensus. 2024 prescription transactions revenue grew 5% to $577.5M, while subscription revenue fell 8% due to the Kroger Savings Club phaseout.
